Trial intelligence / Profile preview

Dysport for lower limb spasticity in children with cerebral palsy and dynamic equinus foot deformity

2009-017709-12Phase 3

Sponsor
Ipsen
Start
Dec 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in lower extremity spasticity and cerebral palsy (CP) comparing Dysport with Placebo (2 arms).

02

Drugs

botulinum toxin type A
03

Conditions

lower extremity spasticitycerebral palsy (CP)

Beyond the preview

Go deeper on 2009-017709-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017709-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call